Method for the long term reduction of body fat stores, insulin r

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514250, 514866, A61K 3144, A61K 31495

Patent

active

053448324

ABSTRACT:
A process for the long term modification and regulation of lipid and glucose metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia or hyperglycemia, or both (these being the hallmarks of noninsulin dependent, or Type II diabetes)--by administration to a vertebrate, animal or human, of a dopamine agonist and a prolactin stimulator. The dopamine agonist and prolactin stimulator are administered in daily dosages, respectively, at a time of day dependent on the normal circadian rhythm of fat and lean members of a similar species. Decreases in body fat deposits result by treatment of an obese species on a daily timed sequence based on circadian rhythms of the peak prolactin, or peak prolactin and peak glucocorticosteroid, blood level established for lean insulin sensitive members of a similar species. The dopamine agonist is administered at the time of, or just after the time of peak plasma prolactin concentration found in lean animals of the same species and the prolactin stimulator is administered at a time just before the plasma prolactin rhythm reaches its peak in lean animals. Insulin resistance, and hyperinsulinemia or hyperglycemia, or both, can also be controlled in humans on a long term basis by treatment corresponding to that of the treatment for obesity. The short term daily injections reset hormonal timing in the neural centers of the brain to produce long term effects.

REFERENCES:
patent: 3074847 (1963-01-01), Bigsby et al.
patent: 3752814 (1973-08-01), Fluckiger et al.
patent: 3752888 (1973-08-01), Fluckiger et al.
patent: 3922347 (1975-11-01), Bach et al.
patent: 4054660 (1977-10-01), Clemens et al.
patent: 4239763 (1980-12-01), Milvec et al.
patent: 4659715 (1987-04-01), Meier et al.
patent: 4749709 (1988-06-01), Meier et al.
patent: 4783469 (1988-11-01), Meier et al.
Wilson, Chrono. Bio. Int. 6:113-121, 1989.
Cincotta et al. Life Sciences 45:2247-2254, 1989.
Cincotta et al. Ann Nutr Metab 33:305-314, 1989.
Cincotta et al. Horm Metabol Res 21:64-68, 1989.
Cincotta et al., J. Endocrinol. 120:385-391, 1989.
Moore et al., Biology of Reproduction 36:47-58, 1987.
Cincotta et al., Experientia 43:416-417, 1987.
Bartness et al., J. Exp. Zoology 244:437-454, 1987.
Emata et al., J. Exp. Zoology 233:29-34, 1985.
Lobato et al. Mol and Cell. Biochem. 67:19-23, 1985.
Cincotta et al. J. Endocrinol. 106:177-181, 1985.
Cincotta et al. J. Endocrinol. 106:173-176, 1985.
Meier et al., Transactions of the American Fisheries Society 113:422-431, 1984.
Eisemann et al., J. of Animal Sci. 59(1)95-104, 1984.
Eisemanmn et al., J. of Animal Sci. 59(1)86-94, 1984.
Meier et al., Current Ornithology 2:303-343, 1984.
Cincotta, J. Endocrinol. 103:141-146, 1984.
Miller et al., J. Interdiscipl. Cycle Res. 14(1):75-84, 1983.
Miller et al., J. Interdiscipl. Cycle Res. 14(2):85-94, 1982.
Ottenweller et al., Life Sciences 28:1033-1040, 1980.
Barnett, Post Graduate Medical J. 56:11-14, 1980.
Horseman et al., General and Comparative Endocrinology 38:269-274, 1979.
Horseman et al., J. Endocr. 82:367-372, 1979.
Meier et al., Circadian hormone basis for seasonal conditions in the gulf killifish Fundulus grandis. In Comparative Endocrinology, 141-144. Galliard et al. (eds), Elsevier/North Holland Biomedical Press, Amsterdam (1978).
Spieler et al., Life Sciences 22:255-258, 1977.
Meier et al., amer. J. of Physiology 232(2):E193-E196, 1977.
Meier et al., Amer. Zool. 16:649-659, 1976.
Meier et al., General and Comparative Endocrinology 26:253-258, 1975.
Meier, Amer. Scientist 61(2)184-187, 1973.
Berle, Acta endocr. Suppl. 173, Abstract No. 104, 1973.
Meier et al., Biology of Reproduction 8:400-410, 1973.
Meier et al., General and Comparative Endocrinology Suppl. 3:499-508, 1972.
Meier et al., Proc. Soc. for Exp. Bio. & Med. 137:408-415, 1971.
Meier et al., Gen. & Comp. Endocrin. 17:311-318, 1971.
Joseph et al., J. Exp. Zool. 178(1):59-62, 1971.
Meier et al., Science 173:1240-42, 1971.
Meier et al., Proc. Soc. Exp. Biol. and Med. 133(4):1113-16, 1970.
Lee et al., J. of Exp. Zool. 166(3):307-316, 1967.
Meier et al., Gen. & Comp. Endocrin. 8(1):110-114, 1967.
Chemical Abstracts (109:66888w) 1988.
(1989) Acta. Diabetol. Lat., vol. No. 26(2), pp. 133-145.
(1982) Chemical Abstracts, vol. No. 96, No. 11, Abstract No. 80405f.
(1990) Chemical Abstracts, vol. No. 112, No. 21, Abstract No. 191532p.
(1984) Chemical Abstracts, vol. No. 101, No. 7, Abstract No. 49205p.
(1982) Chemical Abstracts, vol. No. 97, No. 19, Abstract No. 156398a.
(1982) Chemical Abstracts, vol. No. 97, No. 3, Abstract No. 17600w.
(1981) Chemical Abstracts, vol. No. 95, No. 1, Abstract No. 530j.
(1980) chemical Abstracts, vol. No. 93, No. 13, Abstract No. 125921c.
(1979) Chemical Abstracts, vol. No. 91, No. 5, Abstract No. 36590k.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for the long term reduction of body fat stores, insulin r does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the long term reduction of body fat stores, insulin r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the long term reduction of body fat stores, insulin r will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1329623

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.